QIPT - NASDAQ

Quipt Home Medical Corp.

QIPT·NASDAQ

$3.65

+0.0000%

HealthcareMedical - Devices

Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. In addition, it provides nebulizers, oxygen concentrators, CPAP and BiPAP units, ventilator equipment and aids, daily and ambulatory aides, equipment solutions, power wheelchairs, oxygen therapy, bariatric equipment, bathroom safety products, bilevel positive airway pressure, canes/crutches, continuous positive airway pressure, CPAP masks and accessories, hospital beds, humidifiers, compressors, patient lifts, walkers, products for wound care, and medical equipment for home-based sleep apnea and chronic obstructive pulmonary disease treatments, as well as rents respiratory equipment. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$162.30M

EPS-0.2500

P/E Ratio-14.60

Earnings Date05/11/2026

394.18M

Assets

60%

3Y+198.0%

5Y+447.0%

10Y+253.0%

171.19M

Total Liabilities

22%

3Y+225.0%

5Y+312.0%

10Y+742.0%

155.98M

Total Equity

46%

3Y+96.0%

5Y+452.0%

10Y+71.0%

Quipt Home Medical Corp. Funding & Solvency Profile

QIPT · NASDAQ

Current Assets

Cash & Cash Equivalents12.92M

Net Receivables34.70M

Inventory25.64M

Other Current Assets35.77M

Total Current Assets109 M

Non-Current Assets

Property, Plant & Equipment64.45M

Goodwill & Intangible Assets139.12M

Long-Term Investments987.00K

Other Non-Current Assets80.61M

Total Non-Current Assets146 M

Total Assets

394.18M

Financial Health Analysis

Current Ratio

1.46x

Acceptable liquidity, but monitor closely. Current assets just barely cover current liabilities.

Debt-to-Equity Ratio

0.77x

Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.

Working Capital

34 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

28% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Quipt Home Medical Corp. Balance Sheet

QIPT • NASDAQ

Quipt Home Medical Corp. Balance Sheet	Sep 2025	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Jun 2009	Jun 2008	Jun 2007	Jun 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	12.9M	16.2M	17.2M	8.5M	34.6M	29.2M	9.7M	3.4M	2.7M	5.2M	38.7M	12.6M	3.3M	250.8K	581.5K	2.8M	77.7K	34.3K	273.2K	23.7K
Short-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6K
Cash & Short-Term Investments	12.9M	16.2M	17.2M	8.5M	34.6M	29.2M	9.7M	3.4M	2.7M	5.2M	38.7M	12.6M	3.3M	250.8K	581.5K	2.8M	77.7K	14.5K	273.2K	23.7K
Net Receivables	34.7M	29.1M	26M	16.4M	11.9M	9.1M	9.4M	9.7M	7.7M	18.3M	18.3M	6.7M	2.3M	708.3K	422.3K	35.9K	88.1K	67.6K	188.7K	191K
Accounts Receivables	34.7M	29.1M	26M	16.4M	11.9M	9.1M	9.4M	9.7M	7.7M	18.3M	18.3M	6.7M	2.3M	697.2K	422.3K	35.9K	88.1K	67.6K	188.7K	231K
Inventory	25.6M	20.9M	18.4M	15.6M	9.3M	6.4M	3.6M	4.4M	7.9M	6.2M	5.4M	1.2M	558.8K	17.5K	70.9K	25.1K	5.7K	0.0	27.3K	100.4K
Prepaids	0.0	6M	0.0	1.1M	1.4M	735.1K	604K	378.5K	662.6K	1.1M	227.9K	99.7K	14.7K	28K	81.6K	20.5K	11.9K	9.9K	114.7K	143.4K
Other Current Assets	35.8M	926K	3.8M	0.0	0.0	-183.1K	2.7K	0.0	-601.8K	0.0	-225.0	0.0	-9.5K	0.0	0.0	0.0	0.0	11.5K	-16.4K	10K
Total Current Assets	109M	73.1M	65.4M	41.5M	57.2M	45.3M	23.3M	17.8M	18.4M	30.8M	62.6M	20.5M	6.2M	1M	1.2M	2.9M	183.4K	103.5K	587.5K	468.5K
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	64.4M	53.9M	53.4M	33.5M	23.5M	12.5M	14.7M	16.2M	16.6M	26.2M	17.3M	8.5M	1.3M	1.4M	1.2M	173.2K	82.6K	144.3K	805.3K	701.7K
Goodwill	61.6M	50.7M	52.8M	28.2M	12.5M	2.9M	1.4M	1.4M	1.4M	18.5M	38.7M	989.7K	0.0	0.0	0.0	0.0	0.0	32.9K	445.5K	296.4K
Intangible Assets	77.6M	68M	74M	28.9M	14.9M	4.2M	2.2M	2.5M	3M	35.9M	40.3M	6.3M	0.0	0.0	0.0	0.0	6.3K	10.9K	13.9K	16.7K
Goodwill & Intangible Assets	139.1M	118.7M	126.9M	57.1M	27.3M	7.1M	3.6M	4M	4.5M	54.4M	79M	7.3M	0.0	0.0	0.0	0.0	6.3K	43.8K	459.4K	313K
Long-Term Investments	987K	1.3M	1.4M	118.2K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Assets	0.0	-275.3K	0.0	-118.2K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	123.3K	0.0
Other Non-Current Assets	80.6M	337K	300.8K	86K	504K	7.2M	71K	89.8K	84.6K	96.6K	94.8K	85.1K	1.1M	226.9K	40.3K	18.9K	-5.2K	531.2K	10.2K	14K
Total Non-Current Assets	285.2M	173.9M	182M	90.7M	51.3M	26.8M	18.4M	20.2M	21.2M	80.7M	96.4M	15.8M	2.4M	1.6M	1.2M	192.1K	83.8K	719.2K	1.4M	1M
Other Assets	0.0	-115.5K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Assets	394.2M	246.9M	247.4M	132.2M	108.6M	72.1M	41.7M	38M	102.6M	111.5M	159M	36.3M	8.5M	2.6M	2.3M	3.1M	267.2K	1.1M	2M	1.5M
LIABILITIES
CURRENT LIABILITIES
Total Payables	38.6M	29.3M	26.2M	19.6M	12.2M	8.3M	6.1M	4.9M	6.9M	7.2M	4.6M	5.7M	2.4M	490K	1.1M	517.3K	0.0	520.1K	877K	839.6K
Accounts Payable	38.4M	29.3M	24.7M	13.8M	9.8M	7.4M	6.1M	4.9M	6.7M	6.9M	3.5M	5.7M	2M	490K	1.1M	517.3K	0.0	520.1K	861.2K	839.6K
Other Payables	152K	0.0	1.5M	5.8M	2.4M	857K	0.0	0.0	274.9K	238.8K	1.2M	0.0	433.9K	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	0.0	1.5M	2.4M	3.5M	3.2M	4.6M	1.8M	1.8M	1.3M	1.6M	5.5M	0.0	0.0	324K	240.6K	160.5K	0.0	0.0	0.0	0.0
Short Term Debt	16.4M	16.1M	17.5M	12.3M	7M	4.3M	8.2M	0.0	0.0	973.6K	2.6M	520.3K	0.0	0.0	0.0	0.0	21.5K	569.3K	778K	154K
Capital Lease Obligations (Current)	6.9M	5.9M	5.1M	3.3M	3M	2M	421K	7.5M	5.4M	4.4M	112K	0.0	0.0	0.0	0.0	0.0	18.2K	0.0	0.0	0.0
Tax Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	980.3K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	4.6M	3.6M	4.5M	3M	7.3M	3.3M	0.0	0.0	0.0	0.0	13.7M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	8.3M	4.6M	4.9M	0.0	0.0	1.8M	1.5M	73.5K	443.9K	502K	84.1K	1.7M	0.0	7.8K	0.0	0.0	285.2K	1.6M	67.4K	859.3K
Total Current Liabilities	74.7M	60.9M	60.6M	41.7M	32.7M	24.4M	18M	14.2M	14.2M	14.7M	26.7M	7.9M	2.4M	821.8K	1.4M	677.9K	325K	2.6M	1.7M	1.9M
NON-CURRENT LIABILITIES
Long Term Debt	82.5M	64.6M	61.3M	3.7M	12.3M	18.2M	11.7M	5.6M	5.1M	5.6M	6.1M	0.0	428.6K	504.4K	0.0	0.0	0.0	0.0	106.2K	150.1K
Deferred Revenue (Non-Current)	0.0	-33.9K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	287K	202K	344K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3M	727.4K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	670K	1.1M	0.0	3.3M	133K	-1.3M	2.7M	0.0	0.0	0.0	-1.6M	15M	4.6M	127.5K	0.0	0.0	-5.2K	0.0	0.0	0.0
Total Non-Current Liabilities	96.5M	79.2M	75.7M	10.9M	17.2M	20.1M	15.4M	8.9M	9.3M	5.6M	7.9M	15.8M	5M	631.9K	0.0	0.0	11.8K	40.8K	476.1K	531.5K
Capital Lease Obligations	19.9M	19.2M	19.2M	10.5M	7.8M	3.9M	8.8M	10.8M	5.4M	4.4M	83.7K	0.0	0.0	0.0	0.0	0.0	35.2K	40.8K	369.8K	422.3K
Total Liabilities	171.2M	140.1M	136.3M	52.7M	50M	41.5M	33.4M	23.1M	30.8M	20.3M	28.1M	23.7M	7.4M	1.5M	1.4M	677.9K	336.9K	2.7M	2.2M	2.4M
SHAREHOLDERS' EQUITY
Common Stock	0.0	0.0	247.5M	214.3M	202.8M	171.4M	152M	150.1M	155.9M	146.8M	135M	16M	6.8M	4.7M	3.8M	0.0	0.0	0.0	0.0	0.0
Additional Paid-In Capital	391.9M	277.8M	27.4M	26.3M	21M	16.5M	16.2M	14.7M	13.8M	14.2M	6.6M	3.9M	893.8K	677.5K	576.8K	4.2M	271.7K	3M	315.5K	240.5K
Retained Earnings	-252.2M	-170.6M	-163.8M	-161M	-165.9M	-159.7M	-215.3M	-159.5M	-106M	-82M	-32.3M	-7.3M	-6.4M	-4.1M	-3.4M	-1.8M	-341.4K	-5.1M	-3.2M	-3.7M
Accumulated Other Comprehensive Income/Loss	0.0	0.0	0.0	0.0	656K	9.9M	9.8M	9.5M	8M	12.1M	13.7M	71.6K	-105.3K	-108.9K	-9.9K	-30.7K	0.0	309.9K	0.0	0.0
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	-10M	54.6M	0.0	0.0	0.0	53.3M	0.0	0.0	10.8K	0.0	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	139.7M	107.2M	111.1M	79.5M	58.6M	28.2M	17.2M	14.9M	71.8M	91.2M	176.4M	12.6M	1.1M	1.1M	958.9K	2.4M	-69.7K	-1.8M	-212.8K	-887.2K
Total Equity	156M	107.2M	111.1M	79.5M	58.6M	28.2M	14.5M	14.9M	71.8M	91.2M	130.9M	12.6M	1.1M	1.1M	958.9K	2.4M	-69.7K	-1.6M	-212.8K	-887.2K
Minority Interest	16.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	210.7K	0.0	0.0
SUMMARY
Total Liabilities & Equity	426M	247.2M	247.4M	132.2M	108.6M	72.1M	41.7M	38M	102.6M	111.5M	159M	36.3M	8.5M	2.6M	2.3M	3.1M	267.2K	1.1M	2M	1.5M
Total Investments	987K	1.3M	1.4M	118.2K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6K
Total Debt	118.8M	99.8M	98M	26.6M	27.1M	27.7M	13.1M	16.3M	13.2M	11M	8.9M	520.3K	428.6K	504.4K	0.0	0.0	56.8K	610.2K	1.2M	685.5K
Net Debt	105.9M	83.6M	80.8M	23M	-7.6M	-1.5M	9.6M	13M	10.2M	5.8M	-32.1M	-11.3M	-2.7M	253.6K	-581.5K	-2.8M	-20.9K	575.9K	929K	1.1M
Shares Outstanding	43,443,972	43,443,972	43,443,972	43,443,972	43,443,972	43,443,972	43,443,972	43,443,972	43,443,972	43,443,972	43,443,972	43,443,972	43,443,972	43,443,972	43,443,972	43,443,972	43,443,972	43,443,972	43,443,972	43,443,972

SEC Filings

QIPT - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	March 16, 2026	March 13, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 06, 2026	March 05, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 03, 2026	March 03, 2026	2026	View Filing
10-Q 10-Q 2025 Q4 Q4	February 09, 2026	December 31, 2025	2025	View Filing
10-K/A 10-K/A 2025 FY (Amended) FY	January 28, 2026	September 30, 2025	2025	View Filing
8-K 8-K 2026 N/A	January 26, 2026	January 22, 2026	2026	View Filing
8-K 8-K 2025 N/A	January 06, 2026	December 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	December 15, 2025	December 15, 2025	2025	View Filing
10-K 10-K 2025 FY FY	December 15, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	December 15, 2025	December 14, 2025	2025	View Filing

Showing 1 to 10 of 112 filings

Related Guides

Blog Categories

Continue your QIPT research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.